Patents by Inventor James Wen

James Wen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10665124
    Abstract: A standard musical score represented in digital format is analyzed for its constituent parts in order to identify notational directives for traversing through the musical score. A linearized version of the musical score is generated that is in substantially the same visual format but allows the reader to traverse through the musical score exclusively in a forward direction and without need for jumps in a reverse direction or forward jumps beyond the subsequent consecutive page. In certain embodiments, forward jumps may be minimally limited to a page within the musical score while in other embodiments a forward jump may be minimally limited to a line or a measure. In yet other embodiments, reverse jumps may be entirely eliminated while in still other embodiments, reverse jumps within pages may remain unchanged.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: May 26, 2020
    Inventor: James Wen
  • Publication number: 20190235710
    Abstract: Embodiments of the present invention disclose a method and system for traversing through digital content displayed on a digital device in a piecewise manner. According to one embodiment, a trigger event is received from a user causing an update of a portion of the display area resulting in discontiguous content being rendered. The balance of the display area is updated with continuous content upon the receipt of a subsequent trigger event.
    Type: Application
    Filed: January 29, 2018
    Publication date: August 1, 2019
    Inventor: James Wen
  • Patent number: 10235527
    Abstract: Methods, systems, and computer-readable media for monitoring states of application packages deployed on a cloud-based application deployment platform. A notification service retrieves a copy of a deployed application package from the cloud-based deployment platform, and determines libraries of the application package. The notification service can then determine security vulnerabilities in the libraries, and provide notifications on the vulnerabilities of the application package to a user or developer.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: March 19, 2019
    Inventors: Michael Dalessio, Justin Smith, John Shahid, James Wen, David Jahn, David E. Goddard, Forest Eckhardt, Mark W. Kropf, James Thomas Bayer, Brandon Shroyer, Kelly Gerritz, Samuel E. Smith, Gabriel Ramirez, Justin Archie, Amin Jamali, Daniel George Rosen
  • Patent number: 10229251
    Abstract: Methods, systems, and computer-readable media for monitoring states of application packages deployed on a cloud-based application deployment platform. A notification service retrieves a copy of a deployed application package and metadata associated with the application package from the cloud-based deployment platform, and identifies libraries of the application package. The notification service can then determine which, if any, libraries are or will become out-of-date, and obtain license information about the libraries. The notification service can provide notifications of any outdated components and on license compatibilities or incompatibilities. The notification service can automatically restage the application package, or update the license, upon finding outdated components or license incompatibilities.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: March 12, 2019
    Assignee: Pivotal Software, Inc.
    Inventors: Michael Dalessio, Justin Smith, John Shahid, James Wen, David Jahn, David E. Goddard, Forest Eckhardt, Mark W. Kropf, James Thomas Bayer, Brandon Shroyer, Kelly Gerritz, Samuel E. Smith, Gabriel Ramirez, Justin T. Archie, Amin Jamali, Daniel George Rosen
  • Publication number: 20180277012
    Abstract: A standard musical score represented in digital format is analyzed for its constituent parts in order to identify notational directives for traversing through the musical score. A linearized version of the musical score is generated that is in substantially the same visual format but allows the reader to traverse through the musical score exclusively in a forward direction and without need for jumps in a reverse direction or forward jumps beyond the subsequent consecutive page. In certain embodiments, forward jumps may be minimally limited to a page within the musical score while in other embodiments a forward jump may be minimally limited to a line or a measure. In yet other embodiments, reverse jumps may be entirely eliminated while in still other embodiments, reverse jumps within pages may remain unchanged.
    Type: Application
    Filed: March 26, 2018
    Publication date: September 27, 2018
    Inventor: James Wen
  • Patent number: 7479495
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula I: Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-? expression utilizing compounds of the present invention are also disclosed.
    Type: Grant
    Filed: June 2, 2005
    Date of Patent: January 20, 2009
    Assignees: Pharmacopeia, Inc., Bristol-Myers Squibb Company
    Inventors: Kevin Joseph Moriarty, Yvonne Shimshock, Gulzar Ahmed, Junjun Wu, James Wen, Wei Li, Shawn David Erickson, Jeffrey John Letourneau, Edward McDonald, Katerina Leftheris, Stephen T. Wrobleski, Zahid Hussain, Ian Henderson, Axel Metzger, John J. Baldwin, Alaric J. Dyckman
  • Publication number: 20050239770
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula I: Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-? expression utilizing compounds of the present invention are also disclosed.
    Type: Application
    Filed: June 2, 2005
    Publication date: October 27, 2005
    Inventors: Kevin Moriarty, Yvonne Shimshock, Gulzar Ahmed, Junjun Wu, James Wen, Wei Li, Shawn Erickson, Jeffrey Letourneau, Edward McDonald, Katerina Leftheris, Stephen Wrobleski, Zahid Hussain, Ian Henderson, Axel Metzger, John Baldwin, Alaric Dyckman
  • Patent number: 6906067
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula I: Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-? expression utilizing compounds of the present invention are also disclosed.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: June 14, 2005
    Assignees: Bristol-Myers Squibb Company, Pharmaceopeia, Inc.
    Inventors: Kevin Joseph Moriarty, Yvonne Shimshock, Gulzar Ahmed, Junjun Wu, James Wen, Wei Li, Shawn David Erickson, Jeffrey John Letourneau, Edward McDonald, Katerina Leftheris, Stephen T. Wrobleski, Zahid Hussain, Ian Henderson, Axel Metzger, John J. Baldwin, Alaric J. Dyckman
  • Publication number: 20030139435
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed.
    Type: Application
    Filed: June 26, 2002
    Publication date: July 24, 2003
    Inventors: Gulzar Ahmed, Axel Metzger, Ian Henderson, David J. Diller, James Wen, Stephen T. Wrobleski, Katerina Leftheris
  • Publication number: 20020137747
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed.
    Type: Application
    Filed: June 26, 2001
    Publication date: September 26, 2002
    Inventors: Kevin Joseph Moriarty, Yvonne Shimshock, Gulzar Ahmed, Junjun Wu, James Wen, Wei Li, Shawn David Erickson, Jeffrey John Letourneau, Edward McDonald, Katerina Leftheris, Stephen T. Wrobleski, Zahid Hussain, Ian Henderson, Axel Metzger, John J. Baldwin, Alaric J. Dyckman
  • Publication number: 20020065270
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed.
    Type: Application
    Filed: December 22, 2000
    Publication date: May 30, 2002
    Inventors: Kevin Joseph Moriarty, Yvonne Shimshock, Gulzar Ahmed, Junjun Wu, James Wen, Wei Li, Shawn David Erickson, Jeffrey John Letourneau, Edward McDonald, Katerina Leftheris, Stephen T. Wrobleski
  • Patent number: D603627
    Type: Grant
    Filed: September 23, 2008
    Date of Patent: November 10, 2009
    Assignee: Elite Manufacturing Corporation
    Inventor: James Wen